Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 3 EP applications Duncan Whitaker has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 18, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13187404

Vaccine

IPC classification:
A61K 39/116, A61P 31/04
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Duncan Whitaker, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12712664

PROCESS FOR PRODUCING AN IMMUNOGENIC COMPOSITION CONTAINING TETANUS TOXOID

IPC classification:
A61K 39/08, A61K 39/39
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Duncan Whitaker, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14750176

COMBINATION IMMUNOGENIC COMPOSITIONS

IPC classification:
A61K 39/00, A61K 39/02, A61K 39/10, A61K 39/155
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED

Please Sign in to use this feature